CM
Claude Maraoui
President & CEODirector

Claude Maraoui insider trades: Journey Medical (DERM) stock buys and sales

President & CEO, Journey Medical Last trade May 2, 2025 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2023
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Claude reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 2, 2025DERM↓ Sell$33K
Mar 11, 2025DERM↓ Sell$247K
Mar 7, 2025DERM↓ Sell$203K
Mar 5, 2025DERM↓ Sell$361K
Mar 22, 2024DERM↑ Buy$35K
Sep 6, 2023DERM↑ Buy$66K
Jul 24, 2023DERM↓ Sell$37K
May 17, 2023DERM↓ Sell$58K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Claude Maraoui's insider trades

Claude Maraoui is President & CEO at Journey Medical (DERM). Since May 17, 2023, Claude has reported 2 open-market purchases worth $100K and 6 sales worth $938K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (3 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DERM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.